Filter
469
Text search:
HPV
Featured
Recommendations
55
New Publications
141
Language
Document type
No document type
258
Guidelines
83
Studies & Reports
58
Manuals
25
Strategic & Response Plan
18
Fact sheets
10
Training Material
8
Brochures
3
Infographics
3
Situation Updates
2
Online Courses
1
Countries / Regions
India
22
Global
21
South Africa
20
Kenya
17
Tanzania
14
Zambia
12
Uganda
9
Germany
9
Malawi
9
Namibia
8
Lesotho
8
Paraguay
8
Nigeria
7
Latin America and the Carribbean
7
Ghana
6
Nepal
6
Africa
6
Burkina Faso
5
Liberia
5
Ethiopia
5
Philippines
5
Rwanda
5
Western and Central Europe
5
Zimbabwe
4
Brazil
4
Botswana
4
Myanmar / Burma
4
East and Southern Africa
4
Middle East and North Africa
4
Sierra Leone
3
Congo, Democratic Republic of
3
Cameroon
3
Mozambique
3
South–East Asia Region
3
Syria
2
Benin
2
Argentina
2
Switzerland
2
Yemen
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Guinea
1
Senegal
1
Niger
1
Togo
1
South Sudan
1
Chad
1
Indonesia
1
Bangladesh
1
Eswatini/ Swaziland
1
Burundi
1
Ukraine
1
Colombia
1
El Salvador
1
Madagascar
1
Chile
1
Laos
1
Russia
1
Moldova
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
207
Clinical Guidelines
73
Women & Child Health
46
Public Health
26
Capacity Building
6
Key Resources
6
Pharmacy & Technologies
4
Toolboxes
HIV
72
COVID-19
33
Refugee
22
NCDs
13
Caregiver
11
TB
9
AMR
9
Pharmacy
8
Global Health Education
7
NTDs
7
Mental Health
6
Conflict
5
Disability
3
Ebola & Marburg
3
Malaria
3
Planetary Health
2
Health Financing Toolbox
2
Polio
1
Natural Hazards
1
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or religious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance
...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
News Release 11 april 2022
Self-care interventions are evidence-based, quality drugs, devices, diagnostics and/or digital products which can be provided fully or partially outside of formal health services and can be used with or without the direct supervision of health care personnel.
Where
...
PLoS ONE 18(5): e0285031. https://doi.org/10.1371/journal.pone.0285031
The study aims to integrate HPV vaccination into routine care in adolescent HIV clinics. To achieve success, we will co-design a package of implementation strategies using a pre
...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin
...
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data
...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inext
...
This fact sheet is based on a systematic review of the literature on HPV and cervical cancer epidemiology, and a survey on policies and practices related to the prevention and control of cervical cancer among women living with HIV (WLHIV) to PAHO Me
...
Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus
(HPV). In 2020, it was the fourth most common cancer among women worldwide, with an estimated 604 000 new cases and 342 000 de
...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance inclu
...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w
...
This Plan envisions a future with the elimination of cervical cancer as a public health problem as a result of universal access to sexual health and STI prevention services, HPV vaccines, effective screening and precancer treatment services, treatme
...
Cervical Cancer Control in India
recommended
A new e-learning course has just been released, aimed at healthcare professionals working with patients in India exploring HPV screening and vaccination, assessment and diagnosis of cervical cancer, and palliative care for patients with advanced cer
...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life course from childhood through to adulthood. These inclu
...
Guía de prácticas esenciales. Segunda edición
Se sabe desde hace tiempo que las mujeres con el VIH presentan un mayor riesgo de desarrollar cáncer cervicouterino; sin embargo, existen pocos datos e información sobre esta afección en la Región de las Américas. Este estudio, realizado entre el 2019 y el 2020, intenta brindar información y d
...
Esta carpeta ofrece información básica acerca de la estrategia de tamizaje basada en el test de VPH. Tiene como principales destinatariosa los integrantes del equipo de salud que realizan las tomas de las muestras para el tamizaje en las provincias que incorporaron esta nueva tecnología [ginecól
...
